COMPASS: The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone: A US Perspective
- Homepage
- >
- Publications
- >
- COMPASS: The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone: A US Perspective
Back To Top